1345.HK - China Pioneer Pharma Holdings Limited

HKSE - HKSE Delayed Price. Currency in HKD
2.450
+0.030 (+1.24%)
At close: 4:08PM HKT
Stock chart is not supported by your current browser
Previous Close2.420
Open0.000
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.000 - 0.000
52 Week Range
Volume0
Avg. Volume1,418,333
Market Cap3.088B
Beta1.35
PE Ratio (TTM)9.29
EPS (TTM)0.264
Earnings DateN/A
Forward Dividend & Yield0.15 (6.20%)
Ex-Dividend Date2017-10-16
1y Target Est3.39
  • Reuters3 months ago

    BRIEF-China Pioneer Pharma Holdings Posts FY Net Profit Of RMB280.6 Mln

    March 21 (Reuters) - China Pioneer Pharma Holdings Ltd : * FY ‍REVENUE INCREASED BY 20.3% TO RMB2,153.9 MILLION​ * ‍FY NET PROFIT INCREASED BY 17.6% TO RMB280.6 MILLION​ Source text for Eikon: Further ...

  • Best SEHK Undervalued Stocks
    Simply Wall St.3 months ago

    Best SEHK Undervalued Stocks

    Companies with shares trading at a market price below what they are actually worth, such as China Pioneer Pharma Holdings and Easy Repay Finance & Investment, are deemed undervalued. There’sRead More...

  • February Top Growth Companies
    Simply Wall St.4 months ago

    February Top Growth Companies

    Most investors find it challenging to find companies with prospective double-digit growth rates that are also financially robust. These hidden gems also add meaningful upside to a portfolio, should theRead More...

  • Top Growth Stocks This Week
    Simply Wall St.5 months ago

    Top Growth Stocks This Week

    Robust, high-growth companies such as Shanghai Haohai Biological Technology are appealing to investors for many reasons. They bring about a strong upside to your portfolio, and less downside risk asRead More...

  • China Pioneer Pharma Holdings Ltd. : Neutral assessment on price but strong on fundamentals
    Capital Cube10 months ago

    China Pioneer Pharma Holdings Ltd. : Neutral assessment on price but strong on fundamentals

    Categories: Yahoo FinanceChina Pioneer Pharma Holdings Ltd. relative valuation is now NEUTRAL. It was previously rated OVERVALUED, and has a fundamental analysis score of 66. Our analysis is based on comparing China Pioneer Pharma Holdings Ltd. with the following peers – Sinopharm Group Co., Ltd. Class H, Livzon Pharmaceutical Group Inc Class H, Tong Ren Tang Technologies ... Read more (Read more...)